These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34054487)
21. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2. Dogan B; Erol MK; Akidan M; Suren E; Akar Y Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862 [TBL] [Abstract][Full Text] [Related]
22. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy. Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209 [TBL] [Abstract][Full Text] [Related]
23. EVALUATION OF MACULAR ISCHEMIA IN EYES WITH BRANCH RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. Kadomoto S; Muraoka Y; Ooto S; Miwa Y; Iida Y; Suzuma K; Murakami T; Ghashut R; Tsujikawa A; Yoshimura N Retina; 2018 Feb; 38(2):272-282. PubMed ID: 28221256 [TBL] [Abstract][Full Text] [Related]
27. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion. Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569 [TBL] [Abstract][Full Text] [Related]
28. Updating Understanding of Macular Microvascular Abnormalities and Their Correlations With the Characteristics and Progression of Macular Edema or Exudation in Coats' Disease. Zhang J; Ruan L; Jiang C; Yang Q; Ju Y; Chang Q; Huang X Front Med (Lausanne); 2022; 9():788001. PubMed ID: 35492340 [TBL] [Abstract][Full Text] [Related]
30. Atypical bilateral presentation in idiopathic macular telangiectasia type 1. Tapia Quijada HE; Mantolan Sarmiento C; Serrano García M; Betancor Caro N Arch Soc Esp Oftalmol (Engl Ed); 2021 Nov; 96(11):602-606. PubMed ID: 34756283 [TBL] [Abstract][Full Text] [Related]
31. Phakic cystoid macular edema secondary to idiopathic macular telangiectasia type 1 responsive to topical anti-inflammatory agents. Dunn EN; Gregori NZ; Goldhardt R Semin Ophthalmol; 2013 Mar; 28(2):84-7. PubMed ID: 23448562 [TBL] [Abstract][Full Text] [Related]
32. Atypical bilateral presentation in idiopathic macular telangiectasia type 1. Tapia Quijada HE; Mantolan Sarmiento C; Serrano García M; Betancor Caro N Arch Soc Esp Oftalmol (Engl Ed); 2020 Dec; ():. PubMed ID: 33309502 [TBL] [Abstract][Full Text] [Related]
33. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography. Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394 [TBL] [Abstract][Full Text] [Related]
34. Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1. Cirafici P; Musolino M; Saccheggiani M; Traverso CE; Nicolò M Case Rep Ophthalmol; 2021; 12(1):92-97. PubMed ID: 33976663 [TBL] [Abstract][Full Text] [Related]
35. Type II idiopathic macular telangiectasia and soft confluent drusen. Querques G; Coscas G; Soubrane G; Souied EH Eur J Ophthalmol; 2010; 20(2):466-8. PubMed ID: 19967665 [TBL] [Abstract][Full Text] [Related]
36. Bevacizumab for the treatment of a complicated posterior melanocytoma. Urrets-Zavalia JA; Crim N; Esposito E; Correa L; Gonzalez-Castellanos ME; Martinez D Clin Ophthalmol; 2015; 9():455-9. PubMed ID: 25834382 [TBL] [Abstract][Full Text] [Related]
37. Intraretinal and subretinal fluid in exudative nonproliferative macular telangiectasia type 2. Manayath GJ; Ninan RS; Verghese S; Narendran V Oman J Ophthalmol; 2022; 15(3):393-396. PubMed ID: 36760925 [TBL] [Abstract][Full Text] [Related]
38. Long-Term Follow-Up of an Atypical Case of Idiopathic Macular Telangiectasia. Mucciolo DP; Murro V; Giorgio D; Sodi A; Virgili G; Rizzo S Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):e278-e283. PubMed ID: 30566714 [TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography. Park YG; Park YH PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375 [TBL] [Abstract][Full Text] [Related]
40. CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS. Osaka R; Shiragami C; Ono A; Kobayashi M; Takasago Y; Yamashita A; Tsujikawa A Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S114-S122. PubMed ID: 28541960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]